title: A priming dose of oral vitamin A given to preschool children may extend protection conferred by a subsequent large dose of vitamin A.
abstract: A randomized trial tested whether a priming dose of vitamin A would extend the protection of a subsequent 60,000-micrograms retinol equivalent (RE) oral dose. Seventy-five xerophthalmic and 74 age- and neighborhood-matched non-xerophthalmic preschool children were randomized to one of three oral regimens of vitamin A, receiving peanut oil only (Group A), 7500 micrograms RE (Group B) or 60,000 micrograms RE (Group C), followed in all instances by 60,000 micrograms RE 1 wk later. Serum retinol was measured 2, 4, 6 and 12 mo following the second dose by technicians unaware of the children's treatment status. Among xerophthalmic children, mean values differed across treatment groups at 2 mo (C > A) and tended to be different at 12 mo (C > A and B > A). Among non-xerophthalmic children mean retinol concentrations differed across treatment groups at 6 mo, but not in a consistent way (A > C > B), and at 12 mo (C > A and B > A). Xerophthalmic children reverted to biochemical deficiency faster than non-xerophthalmic children. A small or large priming dose may extend the protection conferred by a 60,000-micrograms RE dose, supporting the use of repeated, spaced doses of vitamin A for treating xerophthalmia. Similar retinol concentrations in Groups B and C at 12 mo suggest the 60,000-micrograms RE prophylactic dose currently recommended by the World Health Organization need not be increased.
authors.affiliation: Dana Center for Preventive Ophthalmology, Johns Hopkins School of Medicine, Baltimore, MD 21287.
authors.forename: J H
authors.initials: JH
authors.lastname: Humphrey
authors.forename: K P
authors.initials: KP
authors.lastname: West
authors.lastname: Muhilal
authors.forename: L C
authors.initials: LC
authors.lastname: See
authors.forename: G
authors.initials: G
authors.lastname: Natadisastra
authors.forename: A
authors.initials: A
authors.lastname: Sommer
mesh_terms: D000284:Administration, Oral; D002675:Child, Preschool; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009755:Night Blindness / Q000188:drug therapy / Q000209:etiology; D014801:Vitamin A / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D014802:Vitamin A Deficiency / Q000150:complications / Q000517:prevention & control*; D014985:Xerophthalmia / Q000097:blood / Q000188:drug therapy* / Q000209:etiology
chemical_list: D014801:Vitamin A